(Q81503145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

5

Toos Daemen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Ninke Leffers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Annechien J A Lambeck

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Pauline de Graeff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Astrid Y Bijlsma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ate G J van der Zee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hans W Nijman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

20 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

365-373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

Novel therapeutic agents in ovarian cancer

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Global cancer statistics, 2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Immunologic aspect of ovarian cancer and p53 as tumor antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

The immunobiology of cancer immunosurveillance and immunoediting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Cancer despite immunosurveillance: immunoselection and immunosubversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Tissue microarrays for high-throughput molecular profiling of tumor specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Validation of tissue microarray technology in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Phase I clinical trial of a human idiotypic p53 vaccine in patients with advanced malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.043

10.1016/J.YGYNO.2008.04.043

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18571704%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference